A new electronic submission tool is now available for CU Boulder Principal Investigators to initiate a Material Transfer Agreement (MTA) or Non-Disclosure Agreement (NDA).This submission form was ...

A material transfer agreement (MTA) is a legally binding agreement between two parties (a “provider” and a “recipient”) for the unfunded transfer of tangible research assets to be used for the ...

A Material Transfer Agreement (MTA) governs the transfer of biological, chemical, archeological and other materials from one organization to another. Usually the materials in question are proprietary ...

The MTO will complete the appropriate transfer document (i.e., agreement, record of transfer, etc.) based on the information provided in the submission package. If additional information or ...

Actual results could differ materially from those currently anticipated due to a number of factors and risks, as discussed in the Company’s Annual Report on Form 20-F for the year ended April 30 ...

An agreement term may require that the recipient indemnify the provider against any damage that may occur through use of the material, implying that the provider is not responsible, even if the ...

NEW YORK, Sept. 24, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous ...

Lexaria previously announced, on September 3, 2024, that it had entered into a Material Transfer Agreement ("MTA") with a pharmaceutical company ("PharmaCO") to evaluate Lexaria's DehydraTECH TM ...

Infinity Enters into Master Clinical Supply Agreement and Material Transfer Agreement with Roche – Roche to Supply Infinity with Gazyva TM for Combination Clinical Studies of Duvelisib (IPI-145) – ...